Sheng An
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Nephrology top 5%
- Acute Kidney Injury Research
Papers in
-
- Sirtuins and Resveratrol in Medicine 2
- Journals
- Cell Death and Disease (2 papers)Frontiers in Immunology (2 papers)Shock (2 papers)International Immunopharmacology (2 papers)PLoS ONE (1 paper)
- Partner nations
- ChinaSouth Sudan
In The Last Decade
Sheng An
16 papers receiving 857 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Geriatrics and Gerontology 124
- Nephrology 106
- Critical Care and Intensive Care Medicine 61
- Biological Psychiatry 19
- Cancer Research 112
Countries citing papers authored by Sheng An
This map shows the geographic impact of Sheng An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng An more than expected).
Fields of papers citing papers by Sheng An
This network shows the impact of papers produced by Sheng An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng An. The network helps show where Sheng An may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sheng An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 96 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 6 | |
| 6 | Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation Hit paper breakdown → | 2023 | 97 |
| 7 | 2022 | 30 | |
| 8 | 2022 | 68 | |
| 9 | 2021 | 32 | |
| 10 | 2021 | 34 | |
| 11 | 2021 | 120 | |
| 12 | 2021 | 86 | |
| 13 | 2021 | 135 | |
| 14 | 2018 | 70 | |
| 15 | 2015 | 5 | |
| 16 | 2014 | 58 |
About Sheng An
Sheng An is a scholar working on Geriatrics and Gerontology, Clinical Biochemistry, Nephrology, Biological Psychiatry and Critical Care and Intensive Care Medicine, having authored 16 papers that have together received 862 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (3 papers), Autophagy in Disease and Therapy (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Acute Kidney Injury Research (3 papers), Sirtuins and Resveratrol in Medicine (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Geriatrics and Gerontology (124 citations), Nephrology (106 citations), Critical Care and Intensive Care Medicine (61 citations), Biological Psychiatry (19 citations) and Cancer Research (112 citations). Sheng An has collaborated with scholars based in China and South Sudan. Frequent co-authors include Zhenhua Zeng, Qiaobing Huang, Jie Wu, Zhongqing Chen, Zhiya Deng, Maomao Sun, Lulan Li, Jiaxin Li, Haihong Fang and Yaoyuan Zhang. Their work appears in journals such as Cell Death and Disease, Frontiers in Immunology, Shock, International Immunopharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.